Open AccessPhase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors
Author(s) -
Matthew Schuelke,
Justin H. Gundelach,
Matt Coffey,
Emma J. West,
Karen J. Scott,
Derek R. Johnson,
Adel Samson,
Alan Melcher,
Richard G. Vile,
Richard J. Bram
Publication year - 2022
Publication title -
neuro-oncology advances
Language(s) - English
Resource type - Journals
ISSN - 2632-2498
DOI - 10.1093/noajnl/vdac085
Subject(s) - medicine , leukopenia , neutropenia , refractory (planetary science) , adverse effect , glioma , oncolytic virus , toxicity , surgery , cancer , physics , cancer research , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom